Research Article
The Effect of Hyperhomocysteinemia on Motor Symptoms, Cognitive Status, and Vascular Risk in Patients with Parkinson’s Disease
Table 4
Comparison of daily levodopa dose and duration of levodopa medication between patients with plasma homocysteine levels ≤14 and >14 µmol/L.
| |||||||||||||||||||||||||||
Data reported as the mean ± SD. |